EDGAR Filing Documents for 0001144204-19-047834

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001144204-19-047834

Filing Date

2019-10-10

Accepted

2019-10-10 09:02:54

Documents

Period of Report

2019-10-10

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 6-K	tv530915_6k.htm	6-K	10741
2	EXHIBIT 99.1	tv530915_ex99-1.htm	EX-99.1	20129
3	GRAPHIC	image_001.jpg	GRAPHIC	11575
	Complete submission text file	0001144204-19-047834.txt		48149

Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018

Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702

Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: 6-K | Act: 34 | File No.: 001-36288 | Film No.: 191145392
SIC: 2834 Pharmaceutical Preparations